Ulcerative colitis Trials in Kashiwa Shi, Japan
Conditions / Ulcerative colitis / Kashiwa Shi, Japan
Research into Ulcerative colitis spans multiple therapeutic approaches and trial phases.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05784246 | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis | RECRUITING | PHASE3 |
| NCT06979336 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC) | RECRUITING | PHASE2 |
| NCT06257875 | A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT05507216 | ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2 | COMPLETED | PHASE3 |
| NCT05535946 | ABTECT - Maintenance | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04277546 | Open-label Extension Study of Brazikumab in Ulcerative Colitis | TERMINATED | PHASE2 |
| NCT03950232 | An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | — |
| NCT03616821 | Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis | TERMINATED | PHASE2 |
| NCT04987307 | Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis | TERMINATED | PHASE2 |
| NCT05782907 | Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis. | ACTIVE_NOT_RECRUITING | PHASE3 |